Clinical trial
Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's…
NCT00003114 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00003114 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With AIDS-Related Hodgkin's Disease |
| Official title | Oral Combination Chemotherapy in the Treatment of AIDS-Associated Hodgkin's Disease |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cyclophosphamide, etoposide, lomustine, procarbazine hydrochloride, radiation therapy |
| Enrollment | 5 |
| Start date | Jul 1, 1997 |
| Primary completion | Jun 1, 2002 |
| Completion | Feb 1, 2003 |
| First posted | Aug 13, 2003 |
| Last update posted | Jun 11, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: